These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 19472317)

  • 21. Differential activation of p53 targets in cells treated with ultraviolet radiation that undergo both apoptosis and growth arrest.
    Reinke V; Lozano G
    Radiat Res; 1997 Aug; 148(2):115-22. PubMed ID: 9254729
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mdm4 (Mdmx) regulates p53-induced growth arrest and neuronal cell death during early embryonic mouse development.
    Migliorini D; Lazzerini Denchi E; Danovi D; Jochemsen A; Capillo M; Gobbi A; Helin K; Pelicci PG; Marine JC
    Mol Cell Biol; 2002 Aug; 22(15):5527-38. PubMed ID: 12101245
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The expression of MDM2, MDM4, p53 and p21 in myeloid neoplasms and the effect of MDM2/MDM4 dual inhibitor.
    Eskandari M; Shi Y; Liu J; Albanese J; Goel S; Verma A; Wang Y
    Leuk Lymphoma; 2021 Jan; 62(1):167-175. PubMed ID: 32924682
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synergistic roles of Mdm2 and Mdm4 for p53 inhibition in central nervous system development.
    Xiong S; Van Pelt CS; Elizondo-Fraire AC; Liu G; Lozano G
    Proc Natl Acad Sci U S A; 2006 Feb; 103(9):3226-31. PubMed ID: 16492743
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aberrant expression of the cell cycle associated proteins TP53, MDM2, p21, p27, cdk4, cyclin D1, RB, and EGFR in cervical carcinomas.
    Skomedal H; Kristensen GB; Lie AK; Holm R
    Gynecol Oncol; 1999 May; 73(2):223-8. PubMed ID: 10329038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MDM4 Is Targeted by 1q Gain and Drives Disease in Burkitt Lymphoma.
    Hüllein J; Słabicki M; Rosolowski M; Jethwa A; Habringer S; Tomska K; Kurilov R; Lu J; Scheinost S; Wagener R; Huang Z; Lukas M; Yavorska O; Helfrich H; Scholtysik R; Bonneau K; Tedesco D; Küppers R; Klapper W; Pott C; Stilgenbauer S; Burkhardt B; Löffler M; Trümper LH; Hummel M; Brors B; Zapatka M; Siebert R; Kreuz M; Keller U; Huber W; Zenz T
    Cancer Res; 2019 Jun; 79(12):3125-3138. PubMed ID: 31000522
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MDM4 (MDMX) localizes at the mitochondria and facilitates the p53-mediated intrinsic-apoptotic pathway.
    Mancini F; Di Conza G; Pellegrino M; Rinaldo C; Prodosmo A; Giglio S; D'Agnano I; Florenzano F; Felicioni L; Buttitta F; Marchetti A; Sacchi A; Pontecorvi A; Soddu S; Moretti F
    EMBO J; 2009 Jul; 28(13):1926-39. PubMed ID: 19521340
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence, causes and impact of TP53-loss phenocopying events in human tumors.
    Fito-Lopez B; Salvadores M; Alvarez MM; Supek F
    BMC Biol; 2023 Apr; 21(1):92. PubMed ID: 37095494
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ets1 is required for p53 transcriptional activity in UV-induced apoptosis in embryonic stem cells.
    Xu D; Wilson TJ; Chan D; De Luca E; Zhou J; Hertzog PJ; Kola I
    EMBO J; 2002 Aug; 21(15):4081-93. PubMed ID: 12145208
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The MDM4/MDM2-p53-IGF1 axis controls axonal regeneration, sprouting and functional recovery after CNS injury.
    Joshi Y; Sória MG; Quadrato G; Inak G; Zhou L; Hervera A; Rathore KI; Elnaggar M; Cucchiarini M; Marine JC; Puttagunta R; Di Giovanni S
    Brain; 2015 Jul; 138(Pt 7):1843-62. PubMed ID: 25981963
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential responses of stress genes to low dose-rate gamma irradiation.
    Amundson SA; Lee RA; Koch-Paiz CA; Bittner ML; Meltzer P; Trent JM; Fornace AJ
    Mol Cancer Res; 2003 Apr; 1(6):445-52. PubMed ID: 12692264
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduced murine double minute 2 and 4 protein, but not messenger RNA, expression is associated with more severe disease in myelodysplastic syndromes and acute myeloblastic leukaemia.
    Salomao N; Maslah N; Giulianelli A; Drevon L; Aguinaga L; Gu X; Cassinat B; Giraudier S; Fenaux P; Fahraeus R
    Br J Haematol; 2023 Apr; 201(2):234-248. PubMed ID: 36546586
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miR-661 downregulates both Mdm2 and Mdm4 to activate p53.
    Hoffman Y; Bublik DR; Pilpel Y; Oren M
    Cell Death Differ; 2014 Feb; 21(2):302-9. PubMed ID: 24141721
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of human MDM4 variants in papillary thyroid carcinomas reveals new potential markers of cancer properties.
    Prodosmo A; Giglio S; Moretti S; Mancini F; Barbi F; Avenia N; Di Conza G; Schünemann HJ; Pistola L; Ludovini V; Sacchi A; Pontecorvi A; Puxeddu E; Moretti F
    J Mol Med (Berl); 2008 May; 86(5):585-96. PubMed ID: 18335186
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rare MDM4 gene amplification in colorectal cancer: The principle of a mutually exclusive relationship between MDM alteration and TP53 inactivation is not applicable.
    Suda T; Yoshihara M; Nakamura Y; Sekiguchi H; Godai TI; Sugano N; Tsuchida K; Shiozawa M; Sakuma Y; Tsuchiya E; Kameda Y; Akaike M; Matsukuma S; Miyagi Y
    Oncol Rep; 2011 Jul; 26(1):49-54. PubMed ID: 21503588
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MDM2 and MDM4 splicing: an integral part of the cancer spliceome.
    Jeyaraj S; O'Brien DM; Chandler DS
    Front Biosci (Landmark Ed); 2009 Jan; 14(7):2647-56. PubMed ID: 19273224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mdm4 loss in mice expressing a p53 hypomorph alters tumor spectrum without improving survival.
    Fang M; Simeonova I; Bardot B; Lejour V; Jaber S; Bouarich-Bourimi R; Morin A; Toledo F
    Oncogene; 2014 Mar; 33(10):1336-9. PubMed ID: 23474762
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Absence of p21 partially rescues Mdm4 loss and uncovers an antiproliferative effect of Mdm4 on cell growth.
    Steinman HA; Sluss HK; Sands AT; Pihan G; Jones SN
    Oncogene; 2004 Jan; 23(1):303-6. PubMed ID: 14712235
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tissue-specific differences of p53 inhibition by Mdm2 and Mdm4.
    Grier JD; Xiong S; Elizondo-Fraire AC; Parant JM; Lozano G
    Mol Cell Biol; 2006 Jan; 26(1):192-8. PubMed ID: 16354690
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mdm4 loss in the intestinal epithelium leads to compartmentalized cell death but no tissue abnormalities.
    Valentin-Vega YA; Box N; Terzian T; Lozano G
    Differentiation; 2009 Jun; 77(5):442-9. PubMed ID: 19371999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.